Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-15-008801
Filing Date
2015-11-12
Accepted
2015-11-12 07:26:10
Documents
4
Period of Report
2015-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp61139_6k.htm 6-K 12080
2 EXHIBIT 99.1 dp61139_ex9901.htm EX-99.1 475207
3 GRAPHIC logo.jpg GRAPHIC 2832
4 GRAPHIC logo1.jpg GRAPHIC 2832
  Complete submission text file 0000950103-15-008801.txt   496313
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37423 | Film No.: 151221404
SIC: 2834 Pharmaceutical Preparations